Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Lane

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Virology|September 1, 1992
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitorsM B Vasudevachari, C Battista, H C Lane, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 1984
Kaposi's sarcoma of the head and neck in the acquired immune deficiency syndromeC A Patow, R Steis, D L Longo, et al.
Annals of Internal Medicine|May 1, 1986
Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workersD K Henderson, A J Saah, B J Zak, et al.
Annals of Internal Medicine|April 1, 1985
Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndromeF P Ognibene, R G Steis, A M Macher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activityJ Falloon, S Piscitelli, S Vogel, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary resultsD L Longo, R G Steis, H C Lane, et al.
Ophthalmology|September 1, 1984
Ophthalmic involvement in acquired immunodeficiency syndromeA G Palestine, M M Rodrigues, A M Macher, et al.
Annals of Internal Medicine|July 1, 1987
Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndromeA F Suffredini, F P Ognibene, E E Lack, et al.
The Journal of Infectious Diseases|December 7, 2000
Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapyH Imamichi, K A Crandall, V Natarajan, et al.
The Journal of Infectious Diseases|July 11, 1991
A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infectionR T Davey, V J Davey, J A Metcalf, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Virology|September 1, 1992
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitorsM B Vasudevachari, C Battista, H C Lane, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 1984
Kaposi's sarcoma of the head and neck in the acquired immune deficiency syndromeC A Patow, R Steis, D L Longo, et al.
Annals of Internal Medicine|May 1, 1986
Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workersD K Henderson, A J Saah, B J Zak, et al.
Annals of Internal Medicine|April 1, 1985
Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndromeF P Ognibene, R G Steis, A M Macher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activityJ Falloon, S Piscitelli, S Vogel, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary resultsD L Longo, R G Steis, H C Lane, et al.
Ophthalmology|September 1, 1984
Ophthalmic involvement in acquired immunodeficiency syndromeA G Palestine, M M Rodrigues, A M Macher, et al.
Annals of Internal Medicine|July 1, 1987
Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndromeA F Suffredini, F P Ognibene, E E Lack, et al.
The Journal of Infectious Diseases|December 7, 2000
Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapyH Imamichi, K A Crandall, V Natarajan, et al.
The Journal of Infectious Diseases|July 11, 1991
A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infectionR T Davey, V J Davey, J A Metcalf, et al.
Pageof 21